Javascript must be enabled to continue!
Monitoring a Mystery: The Unknown Right Ventricle during Left Ventricular Unloading with Impella in Patients with Cardiogenic Shock
View through CrossRef
Background: Right ventricular (RV) dysfunction or failure occurs in more than 30% of patients in cardiogenic shock (CS). However, the importance of timely diagnosis of prognostically relevant impairment of RV function is often underestimated. Moreover, data regarding the impact of mechanical circulatory support like the Impella on RV function are rare. Here, we investigated the effects of the left ventricular (LV) Impella on RV function. Moreover, we aimed to identify the most optimal and the earliest applicable parameter for bedside monitoring of RV function by comparing the predictive abilities of three common RV function parameters: the pulmonary artery pulsatility index (PAPi), the ratio of right atrial pressure to pulmonary capillary wedge pressure (RA/PCWP), and the right ventricular stroke work index (RVSWI). Methods: The data of 50 patients with CS complicating myocardial infarction, supported with different flow levels of LV Impella, were retrospectively analyzed. Results: Enhancing Impella flow (1.5 to 2.5 L/min ± 0.4 L/min) did not lead to a significant variation in PAPi (p = 0.717), RA/PCWP (p = 0.601), or RVSWI (p = 0.608), indicating no additional burden for the RV. PAPi revealed the best ability to connect RV function with global hemodynamic parameters, i.e., cardiac index (CI; p < 0.001, 95% CI: 0.181–0.663), pulmonary capillary wedge pressure (PCWP; p = 0.005, 95% CI: −6.721–−1.26), central venous pressure (CVP; p < 0.001, 95% CI: −7.89–5.575), and indicators of tissue perfusion (central venous oxygen saturation (SvO2); p = 0.008, 95% CI: 1.096–7.196). Conclusions: LV Impella does not impair RV function. Moreover, PAPi seems to be to the most effective and valid predictor for early bedside monitoring of RV function.
Title: Monitoring a Mystery: The Unknown Right Ventricle during Left Ventricular Unloading with Impella in Patients with Cardiogenic Shock
Description:
Background: Right ventricular (RV) dysfunction or failure occurs in more than 30% of patients in cardiogenic shock (CS).
However, the importance of timely diagnosis of prognostically relevant impairment of RV function is often underestimated.
Moreover, data regarding the impact of mechanical circulatory support like the Impella on RV function are rare.
Here, we investigated the effects of the left ventricular (LV) Impella on RV function.
Moreover, we aimed to identify the most optimal and the earliest applicable parameter for bedside monitoring of RV function by comparing the predictive abilities of three common RV function parameters: the pulmonary artery pulsatility index (PAPi), the ratio of right atrial pressure to pulmonary capillary wedge pressure (RA/PCWP), and the right ventricular stroke work index (RVSWI).
Methods: The data of 50 patients with CS complicating myocardial infarction, supported with different flow levels of LV Impella, were retrospectively analyzed.
Results: Enhancing Impella flow (1.
5 to 2.
5 L/min ± 0.
4 L/min) did not lead to a significant variation in PAPi (p = 0.
717), RA/PCWP (p = 0.
601), or RVSWI (p = 0.
608), indicating no additional burden for the RV.
PAPi revealed the best ability to connect RV function with global hemodynamic parameters, i.
e.
, cardiac index (CI; p < 0.
001, 95% CI: 0.
181–0.
663), pulmonary capillary wedge pressure (PCWP; p = 0.
005, 95% CI: −6.
721–−1.
26), central venous pressure (CVP; p < 0.
001, 95% CI: −7.
89–5.
575), and indicators of tissue perfusion (central venous oxygen saturation (SvO2); p = 0.
008, 95% CI: 1.
096–7.
196).
Conclusions: LV Impella does not impair RV function.
Moreover, PAPi seems to be to the most effective and valid predictor for early bedside monitoring of RV function.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Pitfalls due to improper positioning of Impella®CP device for left ventricular support: a case series
Pitfalls due to improper positioning of Impella®CP device for left ventricular support: a case series
Background: The Impella® device is a type of antegrade left ventricular assist device that includes a pump catheter designed to reside in the mid-left ventricular cavity. It has re...
Renal Protection and Hemodynamic Improvement by Impella® Microaxial Pump in Patients with Cardiogenic Shock
Renal Protection and Hemodynamic Improvement by Impella® Microaxial Pump in Patients with Cardiogenic Shock
Acute kidney injury is one of the most frequent and prognostically relevant complications in cardiogenic shock. The purpose of this study was to evaluate the potential effect of th...
Increasing use of the Impella®-pump in severe cardiogenic shock: a word of caution
Increasing use of the Impella®-pump in severe cardiogenic shock: a word of caution
Abstract
Impella® pumps are increasingly utilized in patients in cardiogenic shock. We report on a case series where Impella support was insufficient, and a switch t...
IABP Versus Impella Support in Cardiogenic Shock: “In Silico” Study
IABP Versus Impella Support in Cardiogenic Shock: “In Silico” Study
Cardiogenic shock (CS) is part of a clinical syndrome consisting of acute left ventricular failure causing severe hypotension leading to inadequate organ and tissue perfusion. The ...
IABP Versus Impella Support in Cardiogenic Shock: “In Silico” Study
IABP Versus Impella Support in Cardiogenic Shock: “In Silico” Study
Cardiogenic shock (CS) is part of a clinical syndrome consisting of acute left ventricular failure causing severe hypotension leading to inadequate organ and tissue perfusion. The ...
Less Invasive Left Ventricular Unloading With Impella May Improve the Clinical Outcomes of Fulminant Myocarditis
Less Invasive Left Ventricular Unloading With Impella May Improve the Clinical Outcomes of Fulminant Myocarditis
Fulminant myocarditis (FM) requiring temporary mechanical circulatory support (t-MCS) has a high mortality rate. Peripheral veno-arterial extracorporeal membrane oxygenation (VA-EC...
Characteristics and outcomes of combination VA-ECMO for cardiogenic shock
Characteristics and outcomes of combination VA-ECMO for cardiogenic shock
Abstract
Background
Use of VA-ECMO for cardiogenic shock is growing exponentially. The impact of VA-ECMO on in-hospital mortalit...

